Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

MimiX Biotherapeutics

mimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine.
2019
11-50
Neuchâtel, Neuchatel, Switzerland
BiotechnologynologyHealth DiagnosticsManufacturingPrecision MedicineTherapeutics

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

10.4K

Last Funding Date

16-10-2023

Startup Stage

Early Stage

Lead Investors

Venture Kick, Heraeus, Hermes Group, DM Capital, Asia Jetway

People

Founders